What Scientific & Regulatory Roadblocks Exist for Developing Stem Cell Therapies for the CNS?

DUBLIN, Ireland--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/reports/c47623) has announced the addition of the Decision Resources, Inc report: New Options for Treating Neurological Disease: Stem Cell Therapy to their offering.

Stem cell therapy development is challenged by controversy, intellectual property issues, and a high failure rate. Despite these challenges, stem cell therapy presents some of the most promising options for hard-to-treat and highly degenerative neurological diseases.

Get the Answers You Need to Shape Your Strategy

Stem cell therapy holds vast potential for treating degeneration or injury in areas of the body that are incapable of autonomous healing, such as the central nervous system (CNS). How can stem cells boost healing in the CNS? What are the limitations of these therapies in the CNS? What scientific and regulatory roadblocks exist for developing stem cell therapies for the CNS?